Mgo One Seven LLC Alnylam Pharmaceuticals, Inc. Transaction History

Mgo One Seven LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2019 Apr 09, 2019	SELL	$72.76 - $93.45 $2,255 - $2,896	-31 Closed	0 $0
Q4 2018 Jan 24, 2019	BUY	$62.67 - $88.33 $1,942 - $2,738	31 New	31 $2,000
Q3 2018 Oct 09, 2018	SELL	$87.52 - $122.67 $1,400 - $1,962	-16 Closed	0 $0
Q1 2018 May 15, 2018	BUY	$115.92 - $148.54 $347 - $445	3 Added 23.08%	16 $2,000
Q4 2017 Feb 16, 2018	BUY	$114.49 - $139.98 $1,488 - $1,819	13	13 $2,000

639

108M

1.15M

1.07M

Ticker ALNY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 123,028,000
Market Cap $31.7B
Description
Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. The company's pipeline of investigational RNAi therapeutics focuses on genetic medicines, cardio-metabolic diseases, hepatic infectious diseases, and central nervous system...

Get notified when there are updates to the investment portfolio of Mgo One Seven LLC, based on Form 13F filings with the SEC.

Stay updated on Mgo One Seven LLC with notifications on news.